The nonprofit is focused on access to precision medicine testing and treatment for former special operations forces personnel ...
NEW YORK – Fifteen drugs will be offered at a lower cost under Medicare Part D beginning in 2027 after the latest round of drug price negotiations between pharma companies and the Centers for Medicare ...
The FDA recently removed non-ambulatory Duchenne patients from the gene therapy's indication, which Sarepta hopes to have reinstated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback